Nation's Leading Oncology and Value-Based Care Experts Join Daymark Health's Clinical Advisory Board

Daymark Health is proud to announce the formation of our Clinical Advisory Board — a distinguished, cross-functional group of renowned physicians, researchers, nurses, and innovators spanning oncology, value-based care, and health policy.

The Board includes:

• Dr. Cardinale Smith, Chief Medical Officer at Memorial Sloan Kettering Cancer Center; 
• Dr. Ezekiel Emanuel, an architect of the Affordable Care Act and Clinical Advisory Board Chair; 
• Dr. David Shulkin, former U.S. Secretary of Veterans Affairs; 
• Dr. Jennifer Malin, a leading oncology value-based care expert; 
• Shelley Fuld Nasso, CEO of Cancer Nation; 
• Dr. Kathi Mooney, a pioneer in tech-enabled cancer care; 
• Carol DeVol, a national population health leader; 
• Dr. Roy Beveridge, former Chief Medical Officer of both Humana and U.S. Oncology, who also serves as Daymark's Executive Board Chair.

Dr. Smith shared her POV on the board: "Daymark has assembled an expert group of clinicians, researchers, and patient advocates with a shared purpose: to completely transform the cancer care experience for patients and the system at large. The Board will shape Daymark's care model and strategy, and support the company in forging new partnerships across the healthcare ecosystem.”

The Clinical Advisory Board is designed to share strategic insight into key areas of Daymark's work, drawing on clinical, operational, and patient perspectives to inform our model and strategy. Our members will also support Daymark in forging new partnerships with health plans, provider groups, and additional partners, and ensure we’re building scalable and high-quality solutions that meet the evolving needs of patients, providers, health plans, and other partners. 

Read the full press release.